Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis

Chrysanthi Mantsiou; Thomas Karagiannis; Panagiota Kakotrichi; Konstantinos Malandris; Ioannis Avgerinos; Aris Liakos; Apostolos Tsapas; Eleni Bekiari

doi:10.1111/dom.14108

Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.14108 ◽

2020 ◽

Vol 22 (10) ◽

pp. 1857-1868 ◽

Cited By ~ 4

Author(s):

Chrysanthi Mantsiou ◽

Thomas Karagiannis ◽

Panagiota Kakotrichi ◽

Konstantinos Malandris ◽

Ioannis Avgerinos ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v2/review1 ◽

2020 ◽

Author(s):

Ling Li

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review6 ◽

2020 ◽

Author(s):

Raquel Comoglio

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review5 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v2/review2 ◽

2020 ◽

Author(s):

Raquel Comoglio

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Author response for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v2/response1 ◽

2020 ◽

Author(s):

Chrysanthi Mantsiou ◽

Thomas Karagiannis ◽

Panagiota Kakotrichi ◽

Konstantinos Malandris ◽

Ioannis Avgerinos ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Author Response ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review4 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Decision letter for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/decision1 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Decision letter for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v2/decision1 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review3 ◽

2020 ◽

Author(s):

Avivit Cahn

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review2 ◽

2020 ◽

Author(s):

Ling Li

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text